Prescription Drugs

Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Failed Dissolution Specification

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back